Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study

por Almalag, Haya M., Alaujan, Shiekha S., Alhazzani, Hawazin S., Alzamel, Lamia A., Tashkandi, Reem S., Alarfaj, Hussain F., Alarfaj, Abdurhman S., Omair, Mohammed A.
Publicado 2022

The Patient Activation Measure in Patients with Rheumatoid Arthritis: A Systematic Review and Cross-Sectional Interview-Based Survey

por Al Juffali, Lobna, Almalag, Haya M, Alswyan, Najd, Almutairi, Jawaher, Alsanea, Dalal, Alarfaj, Hussain F, Alarfaj, Abdurhman S, Abouzaid, Hanan H, Omair, Mohammed A
Publicado 2022

Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia

por Almuhareb, Aseel M., Alhawassi, Tariq M., Alghamdi, Ahmed A., Omair, Mohammed A., Alarfaj, Hussain, Alarfaj, Abdulrahman, Alomari, Bedor A., Alblowi, Maysoon S., Almalag, Haya M.
Publicado 2019

Relationship between different anti-rheumatic drug therapies and complementary and alternative medicine in patients with rheumatoid arthritis: an interview based cross-sectional st...

por Almalag, Haya M., Almuhareb, Aseel M., Alsharafi, Aya A., Alhawassi, Tariq M., Alghamdi, Ahmed A., Alarfaj, Hussain, Omair, Mohammed A., Alomari, Bedor A., Alblowi, Maysoon S., Abouzaid, Hanan H., Alarfaj, Abdurhman S.
Publicado 2021